Candidates for 2016 ERP of the Year

66-67 / 328

data that exists in support of this method's
applicability to the SMPR 2014.012 or
2014.010.
Covance, Song)
PDE5-004 Title: Testing for Phosphodiesterase
Type 5 (PDE5) Inhibitors in Dietary
Supplements
Submitter: Said Goueli, Promega
Note: This method was supplemented
with a presentation from the method
author.
Motion 1:
MOTION to not move PDE5-004 to First Action
Official MethodsSM status.
Motion 2:
MOTION that ERP finds this method valuable for
screening and would like to see a further submission
of data demonstrating applicability towards the
SMPR 2014.012.
Motion 1:
Phillips/Sullivan,
7/0/1 (Abstain:
Covance)
Motion 2:
Phillips/Spzylka,
7/0/1 (Abstain:
Covance)
Primary:
Jerry
Zweigenbaum
Secondary:
Teresa Cain
PDE5-005 Title: SLV Study of a Method for
Screening
Submitter: Katerina Mastovska,
Covance
Motion 1:
MOTION to move PDE5-005 to First Action Official
MethodsSMstatus.
Motion 2:
MOTION to be considered for Final Action Official
MethodsSM status, the method author(s) should:
1. Provide reproducibility data
2. Break out AOAC SMPR 2014.011:
-Matrix match spike recovery
-Recovery options
3. Beak out AOAC SMPR 2014.012 and AOAC
SMPR 2014.010.
-Feedback from other users and a
mechanism to receive that feedback.
Motion 1:
Phillips/Koerner,
5/0/2 (Mastovska ,
Sullivan)
Motion 2:
Phillips/Spzylka,
5/0/2 (Mastovska ,
Sullivan)
Primary:
Teresa Cain
Secondary:
Tom Phillips
ERP PROFILE SUMMARIES
60